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ARTICLE
The UPR sensor IRE1α and the adenovirus E3-19K
glycoprotein sustain persistent and lytic infections
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Hans-Gerhard Burgert3,5 & Urs F. Greber 1✉
Persistent viruses cause chronic disease, and threaten the lives of immunosuppressed indi-
viduals. Here, we elucidate a mechanism supporting the persistence of human adenovirus
(AdV), a virus that can kill immunosuppressed patients. Cell biological analyses, genetics and
chemical interference demonstrate that one of five AdV membrane proteins, the E3-19K
glycoprotein specifically triggers the unfolded protein response (UPR) sensor IRE1α in the
endoplasmic reticulum (ER), but not other UPR sensors, such as protein kinase R-like ER
kinase (PERK) and activating transcription factor 6 (ATF6). The E3-19K lumenal domain
activates the IRE1α nuclease, which initiates mRNA splicing of X-box binding protein-1 (XBP1).
XBP1s binds to the viral E1A-enhancer/promoter sequence, and boosts E1A transcription, E3-
19K levels and lytic infection. Inhibition of IRE1α nuclease interrupts the five components
feedforward loop, E1A, E3-19K, IRE1α, XBP1s, E1A enhancer/promoter. This loop sustains
persistent infection in the presence of the immune activator interferon, and lytic infection in
the absence of interferon.
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athogens persist within host cells, which makes them dif-
ficult to treat as they minimally interfere with the host and
escape immune clearance. Viral persistence comprises
chronic and latent infections, for example, human immunodefi-
ciency virus (HIV), herpesvirus, papilloma virus, polyoma virus,
hepatitis B virus, and human adenovirus (AdV)1–3. Viral persis-
tence involves the restoration of homeostasis upon initial infec-
tion. The unfolded protein response (UPR) restores homeostasis
upon ER stress. Enveloped viruses, including influenza virus and
herpes viruses subvert the UPR for the synthesis of viral glyco-
proteins4–6. They involve three transmembrane sensors in the ER,
the inositol-requiring enzyme 1 (IRE1), activating transcription
factor 6 (ATF6/p90), and protein kinase RNA-like ER kinase
(PERK). IRE1α, ATF6, and PERK enhance the levels of the
transcription factors XBP1s, ATF6/p50, and ATF4, respectively,
and upregulate gene expression of chaperones and slow down
protein translation restoring ER homeostasis7–10. IRE1α has
cytoplasmic kinase and nuclease domains. Its phosphorylation
enhances ATP binding, activates the ribonuclease, and initiates
the splicing of XBP1 mRNA by removing a short intron of 26
nucleotides (nt)11. Back-ligation of the spliced mRNA by the
tRNA ligase Rtcb generates XBP1s mRNA encoding the func-
tional transcription factor XBP1s12. During the lytic cycle, Kaposi
sarcoma herpesvirus activates all three UPR sensors, and inhibits
the downstream transcription of host genes by yet unknown
mechanisms reviewed in ref. 13.
Here, we explored how the UPR affected the nonenveloped non-
enveloped AdV. AdVs are widespread pathogens causing self-
limiting disease in the eyes (species B, D, and E), the upper and
lower respiratory tracts (species B, C, and E), and the gastro-
intestinal tract (species F and G)14. AdV-B, C, E, and F persist in
lymphoid and other cell types of the digestive tracts, and produce
low levels of particles in the presence of cellular and humoral
cytokines, interferon (IFN) type I, or the proinflammatory IFN-
γ15–18. In immunocompromised or stressed individuals, AdVs give
rise to morbidity and mortality19,20.
AdV enters cells by receptor-mediated endocytosis, endosomal
rupture, and cytoplasmic transport, and dismantles the capsid to
deliver viral DNA (vDNA) into the nucleus for progeny pro-
duction and establishment of persistence21–23. Expression of the
immediate early viral E1A gene gives rise to transactivators from
alternatively spliced mRNA24,25. E1A proteins interact with
numerous host proteins on double-stranded DNA, and control
host transcription, the cell cycle, DNA replication, and suppress
the expression of IFN-stimulated genes. They activate all early
AdV promoters, including those controlling E1B, E2, E3, and E4,
and drive viral replication21,26,27.
The E3 transcription unit protects the host from disease,
especially uncontrolled inflammatory response, and the virus
from eradication28–31. AdV-C E3 encodes seven open-reading
frames (ORFs), five of which are membrane proteins. The E3A
region gives rise to CR1-alpha, also known as 7.1K (AdV-C5) or
6.7K (AdV-C2), which inhibit apoptosis by degrading the TNF-
related apoptosis-inducing ligand (TRAIL) receptor 2. The gly-
coprotein E3-19K (short 19K) and the AdV death protein (ADP
in AdV-C) of E3A suppress cellular immune responses and
may promote lytic virus release, respectively29. 19K suppresses
the adaptive immune response toward AdV-infected cells by
blocking the transport of MHC class-I molecules from the ER to
the cell surface, and reduces the activation of cytotoxic CD8
T cells and NK cells32–35. The E3B region encodes RIDα and
RIDβ blocking apoptosis mediated through tumor necrosis factor
(TNF), Fas ligand, and TRAIL signaling.
Recent studies with telomerase reverse transcriptase (TERT)-
immortalized human dermal fibroblasts established a persistence
model for AdV, where IFN-I or IFN-II suppresses AdV-C5
infection by reducing the recruitment of the positive transcription
regulator GABPα/β, and enhancing the E2F/Rb repressor com-
plex on the E1A promoter sequence36. Removal of IFN leads to
virus lytic release, akin to acutely immunosuppressed patients17.
Here, we show that the AdV glycoprotein 19K selectively activates
IRE1α but not PERK and ATF6. This gives rise to a transcrip-
tional feedforward loop, including five components—19K, IRE1α,
XBP1s, the E1A enhancer/promoter (e/p), and E1A protein. This
loop maintains long-term viral persistence in the presence of IFN,
and boosts lytic infection in the absence of IFN.
Results
IRE1α-mediated XBP1 splicing enhances AdV infection.
Mammalian cells express two homologs of the yeast Ire1p, IRE1α
(encoded by the ERN1 gene) and IRE1β (ERN2), the latter in a
tissue-specific manner, for example in the digestive tract37,38. To
explore the role of IRE1α in AdV infection, we used CRISPR/
Cas9 to generate IRE1α-knockout HeLa cells (HeLa I-KO). A
guide RNA targeting exon 2 yielded a KO phenotype affecting all
three allelic copies of IRE1α (Fig. 1a, Supplementary Fig. 1a, b).
Two IRE1α alleles were edited by frameshift mutations and one
had a 15-nt in-frame deletion. HeLa I-KO was significantly less
susceptible to AdV-C5 infection than HeLa or HeLa I-KO ecto-
pically expressing IRE1α from a lentivirus, as shown by AdV late
protein VI expression and virus production (Fig. 1a). Infection
inhibition was not due to reduced virus entry, as the incoming
vDNA was effectively delivered into the nucleus 2.5 hpi39 (Sup-
plementary Fig. 1c). Akin to IRE1α KO, the IRE1α nuclease
inhibitor 4µ8C40 reduced viral replication, as shown by quanti-
tative (q)-PCR (Fig. 1a).
To test if AdV infection enhanced the IRE1α nuclease activity,
we measured the levels of XBP1s by quantitative reverse
transcriptase (qrt) PCR in extracts of infected HeLa and HeLa I-
KO cells41. AdV-C5 infection consistently increased the XBP1s
mRNA levels at 24, 48, or 72 hpi (Fig. 1b). Note that the band
denoted with asterisk (*) is a background product and can be
removed by EndoT digest (see Supplementary Fig. 1d). XBP1s
(denoted as 1S) was not enhanced in HeLa I-KO cells, but restored
by ectopic expression of IRE1α (Fig. 1b). Importantly, XBP1s
induction occurred in AdV-C2 or C5-infected HeLa and human
corneal epithelial (HCE) cells, or in diploid human fibroblasts WI-
38, but not in cells infected with AdV-C5 lacking the E1 region
(Fig. 1b, Supplementary Fig. 1e–g). E1 encodes the E1A immediate
early transactivator protein, the antiapoptotic E1B-19K and E1B-
55K proteins24,42. Collectively, the data show that AdV infection
of both transformed and nontransformed non-transformed
human cells induces XBP1s depending on IRE1α and the early
viral genes E1A–E1B.
Phosphorylation of IRE1α and not PERK in AdV infection. We
next tested if XBP1s induction was conserved in murine cells.
AdV-C5 infection for 24–48 h readily induced XBP1s in mouse
embryonic fibroblasts (MEFs) expressing Flag-IRE1α, but not in
cells lacking IRE1α (I-KO)43, akin to the short-term chemical
stimulation of ER stress by thapsigargin (5 h), which inhibits the
ER calcium pump and depletes calcium ions from ER stores44
(Fig. 2a). Both I-KO and normal MEFs were readily infected with
AdV-C2, as indicated by the expression of the early 19K
glycoprotein.
To test if AdV-C5 activated IRE1α, we analyzed the migration
of the endogenous IRE1α protein in SDS-PAGE containing Phos-
Tag. Such gels retard the migration of phosphoproteins relative to
the nonphosphoproteins. IRE1α migration was retarded upon
AdV-C5 infection at 16 or 24 hpi, and retardation blunted by
treatment of the cell lysates with phosphatase (Fig. 2b). In
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contrast, PERK did not show an upward shift upon AdV-C5
infection, unlike treatment with the reducing agent dithiothreitol
(DTT), a known activator of PERK45 (Fig. 2c). We found no
evidence that AdV-C5 induced the regulated IRE1α-dependent
decay (RIDD) pathway, unlike DTT, as assayed with Bloc1S1
mRNA (see Supplementary Fig. 2a).
BiP dissociates from IRE1α in AdV infection independent of
19K. In UPR, the association of the ER chaperone BiP/Grp78
(BiP) with IRE1α decreases upon initial ER stress, and restores
under persistent UPR stimulation, when BiP and co-chaperones
are transcriptionally induced46,47. We assessed the levels of
BiP–IRE1α by immunoprecipitation experiments of Flag-hIRE1α
expressed in IRE1α−/−MEFs at near-endogenous levels43. The co-
immunoprecipitation data, western blots, and rt-PCR measure-
ments of E1A mRNA showed that BiP dissociated from IRE1α at
7 hpi, when only low amounts of E1A protein were present, and
neither 19K protein nor XBP1 splicing were detectable (Fig. 2d).
This was in contrast to conventional UPR induced by DTT where
BiP–IRE1α dissociation was rapidly followed by XBP1 splicing
(Supplementary Fig. 2b). Similar results were obtained in HeLa I-
KO cells transduced with lentivirus encoding Flag-hIRE1α, where
BiP dissociated from IRE1α at 4 h post AdV-C2 infection (Sup-
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Fig. 1 IRE1α activation enhances AdV infection of HeLa cells. a IRE1α-knockout (I-KO) HeLa cells are less susceptible to infection by AdV-C5 (MOI 75, 75
vp/cell) compared with normal HeLa, as indicated by late viral protein VI expression, whereas the ectopic lentivirus-mediated expression of IRE1α in HeLa
I-KO cells restores infection (left panel, upper row middle and right panels showing representative images and quantifications, respectively. Scale bar, 200
µm). Data show the means ± SD from four independent experiments. Reduced virus growth in HeLa I-KO cells compared with wild-type cells. Cells were
infected with AdV-C5 (MOI 500) for 1 h at 37 °C (equivalent to MOI 50 in continuous infection), unbound virus washed off, and virus titers from cells and
supernatant measured at 48 and 72 hpi (lower row middle panel). Data show the means from two independent experiments. The IRE1α endonuclease
inhibitor 4µ8C reduces AdV-C5 titers in long-term infections of HDF-TERT cells (lower row, right panel). HDF-TERT cells were infected with AdV-C5 (MOI
200, 37 °C, 1 h), followed by addition of 4µ8C (100 µM) 13 days pi. Data show the means from two independent experiments. b. IRE1α and the expression
of the viral E1A protein are required to enhance XBP1 splicing in AdV-C2 and C5 infections. Rescue of XBP1 splicing in AdV-infected I-KO cells by IRE1α
overexpression (first panel). Cells were transduced and infected as in a; cell lysates were subjected to XBP1 splicing assays at 24 hpi. Reduced XBP1s
transcripts in HeLa I-KO compared with normal HeLa cells upon AdV-C5 infection (MOI 5, second panel). Data show the means ± SD from three
independent experiments. XBP1 splicing in human conjunctival epithelial cells infected with AdV-C2 or C5 (MOI 75, third panel). E1A-deleted AdV-C5
mutant does not activate XBP1 splicing in HeLa cells 24 hpi (MOI 200 each, fourth panel). The asterisk denotes a background product. Source data are
provided as a Source Data file.
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ORFs did not dissociate BiP from IRE1α, in contrast to a mutant
lacking the 19K ORF (Fig. 2e). Notably, AdV-C5 infection did not
increase the levels of BiP and IRE1α, unlike treatment with DTT,
which massively increased the BiP levels (Fig. 2f). Accordingly, the
ectopic expression of BiP did not attenuate the induction of XBP1s
by AdV-C2, unlike thapsigargin treatment (Supplementary Fig. 2e,
f), consistent with earlier reports46. Collectively, the data indicate
that AdV activates IRE1α in a non-canonical manner, whereby
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An early AdV gene product activates IRE1α. E1A activates all
early viral promoters, and together with E1B enhances trans-
formation and replication48,49. We assessed if viral replication
was required for the IRE1α/XBP1s induction by treating HeLa
cells with the nucleoside analog cytosine arabinoside (AraC),
which blocks viral replication and late protein expression past
the immediate early phase of E1A induction50,51. AraC neither
affected the E1A expression nor the levels of XBP1s (Supple-
mentary Fig. 3a). In contrast, an inhibitor of the positive tran-
scription elongation factor, flavopiridol, blocked E1A expression
24 hpi as expected52, and wiped out the induction of XBP1s
(Supplementary Fig. 3b). The data reinforce the notion that E1A
is required for XBP1s induction.
The lumenal domain of C2/5–19K activates IRE1α. We used a
range of E3 mutant viruses to test for induction of XBP1s
(Fig. 3a). AdV-C5-dl327 lacks 7.1K, 19K, ADP, and RIDα/β53,
dl309 lacks RIDα/β and 14.7K54, and AdV-C2-dE3B has a dele-
tion of RIDα/β55. The deletions in dl327 and dl309 were validated
by PCR, and in addition, all three viruses were found to express E1A
and 19K, except dl327 that lacked 19K (Supplementary Fig. 3c).
Importantly, dl327 did not activate IRE1α unlike dl309 and AdV-
C2-dE3b (Fig. 3a).
We investigated the role of 19K in the activation of IRE1α in
HDF-TERT cells. Phos-tag SDS-PAGE indicated that a mutant
lacking the 19K ORF (AdV-C5-Δ19K) poorly induced IRE1α
phosphorylation, and barely induced XBP1s at 24 hpi unlike
AdV-C5 (Fig. 3b). Similar results were obtained in time-course
studies in HeLa cells (Supplementary Fig. 3d). Remarkably, the
AdV-C5-Δ19K-infected cells showed reduced E1A expression
levels compared with AdV-C5. This finding was in accordance
with the RNAi data against 19K, where a pool of more than a
dozen synthetic dsRNAs targeting 19K strongly reduced the
induction of XBP1s, and also reduced the expression of E1A,
while control RNAi pools against E4-Orf4 had no effect on E1A
(Supplementary Fig. 3e).
To test if 19K was sufficient for the induction of XBP1s, we
coexpressed the AdV-C5 E3A ORFs 12.5K, 7.1K, ADP, and 19K.
Together, they strongly induced XBP1s in HeLa cells (Fig. 3c).
The abrogation of individual ORFs demonstrated that expression
of 19K was necessary for XBP1s induction (Fig. 3c, Supplemen-
tary Fig. 3f). The expression of 19K alone was sufficient to induce
XBP1s, but not PERK phosphorylation, unlike DTT (Fig. 3c).
The 19K glycoprotein has an N-terminal cleavable signal
sequence, a transmembrane segment, and a small cytosolic tail
with a di-lysine ER retention signal56. To identify the domain that
triggered IRE1α activation, we expressed 19K chimeras with
transmembrane and cytoplasmic domains from murine MHC-I
H-2Kd in HeLa cells35. All three chimeras had comparable
expression levels and induced XBP1s, but 19K lacking the LD
only weakly induced XBP1s (Fig. 3d, and Supplementary Fig. 3g).
The human MHC class-I antigen binding defective M87A 19K
mutant35 strongly induced XBP1s, indicating that MHC-I
binding was not required for XBP1s induction (Fig. 3d). The
expression of the C2 19K-LD alone with or without a C-terminal
HDEL motif activated IRE1α to comparable levels as the full-
length protein, and much more effectively than the D8 19K-LD or
full-length 19K (Fig. 3e, Supplementary Fig. 3h, i). The AdV-C2/
5–19K glycoproteins have a highly conserved LD of 122 and 123
amino acids, 92% of which are identical, whereas the D8-LD of
119 amino acids is 30% identical with the C2/5-LDs (Supple-
mentary Fig. 3j). This underscores that 19K alone or in context of
AdV-C infection induces the phosphorylation of endogenous
IRE1α followed by XBP1 splicing. This suggests the formation of
IRE1α oligomers triggering trans-autophosphorylation and allos-
teric activation of the endonuclease domain9.
The C2-19K lumenal domain interacts with IRE1α but not
PERK. To test if 19K interacted with IRE1α, we stably expressed C2
19K in human embryonic kidney (HEK) 293 cells, yielding a reti-
cular ER-like pattern in the cytoplasm (Supplementary Fig. 4a).
Immunoprecipitation of 19K by the monoclonal IgG antibody
3A9 significantly enriched IRE1α compared with pulldowns with a
control IgG, suggesting a complex of IRE1α and 19K. We next
tested if the lumenal domains of C2-19 K and IRE1α interacted in
the ER. Tripartite split-GFP fluorescence complementation assays
were used in cells expressing the 19K-LD and IRE1α or PERK-LD.
The Flag-IRE1α containing the 20-amino-acid domain GFP10 at the
C terminus and the C2 19K-LD with the C-terminal 18 amino acids
of GFP11 gave rise to reticular ER-like green fluorescence signals in
transfected cells expressing signal sequence containing GFP1–9 with
a HDEL ER retention signal (Fig. 4a, b). Green fluorescence signals
colocalized with the anti-19K and anti-Flag immunostainings vali-
dating the GFP complementation signals. In contrast, no green
fluorescence was obtained with Flag-tagged PERK-GFP10-LD,
although both 19K and PERK localized in reticular cytoplasmic
Fig. 2 AdV infection of mouse embryonic fibroblasts induces XBP1 splicing and displaces BiP/Grp78 from IRE1α. a Flag-IRE1α-expressing MEFs but not
IRE1α-KO MEFs induce XBP1s upon AdV-C2 infection (MOI 300) or thapsigargin (Tg, 10 µM) treatment (left panel). Representative immunofluorescence
images with the anti-19K antibody 3A9 showing 19K expression in AdV-C-infected IRE1α-KO MEFs and Flag-IRE1α-expressing IRE1α-KO MEFs 24 hpi
(clones 30 and 574, respectively, right panel, scale bar, 20 µm). Three independent experiments gave similar results. Source data are provided as a Source
Data file. b AdV induces phosphorylation of IRE1α. Flag-IRE1α expressing IRE1α-KO MEFs at 7, 16, and 24 hpi with AdV-C5 (MOI 300) immunoblotted with
anti-IRE1α antibody. Lysates were resolved on a 6% SDS-PAGE gel containing 25 µM Phos-tag. Samples were treated with or without alkaline phosphatase.
Phosphorylated (p) and hypophosphorylated (o) forms of IRE1α are indicated by the dashed lines, and the percentage of IRE1α phosphorylated was
calculated as indicated. Lysates are the same as in panel D demonstrating β-tubulin loading. Three independent experiments gave similar results. Source
data are provided as a Source Data file. c AdV-C5 infection of HeLa cells (MOI 200) does not activate PERK, unlike treatment of cells with the reducing
agent DTT. Activated phosphorylated PERK is indicated by p, and the inactive form by o. Two independent experiments gave similar results. d BiP
displacement from IRE1α occurs before XBP1 splicing in Flag-IRE1α-expressing IRE1α-KO MEFs infected with AdV-C5 (MOI 300). Cells were lysed and
BiP–IRE1α complexes immunoprecipitated (IP) with anti-Flag antibody, and a western blot with anti-IRE1α, anti-BiP, and anti-β-tubulin antibodies was
performed. A separate non-reducing immunoblot probed with anti-19K Tw1.3 antibodies revealed monomeric and dimer forms of 19K indicated as mo and
di, respectively. Input lysates were 1% of the immunoprecipitated samples. The corresponding samples were also analyzed for XBP1 splicing and E1A mRNA
levels by rt-PCR (reverse transcription polymerase chain reaction), as indicated. Three independent experiments gave similar results. Source data are
provided as a Source Data file. e BiP–IRE1α dissociation requires E1, not 19K. Co-immunoprecipitation of Flag-IRE1α and BiP was performed as described in
d with AdV mutants lacking E1 (AdV-C5-∆E1) and 19K (AdV-C5-Δ19K) at MOI 300 each. Two independent experiments gave similar results. Source data
are provided as a Source Data file. f AdV-C5 infection does not increase BiP/Grp78 and IRE1α levels given in arbitrary units (a.u.), unlike the canonical UPR
triggered by DTT (2mM). The bar graph shows the normalized levels of IRE1α and BiP from three independent experiments. Data show the means ± SD
from three independent experiments. Source data are provided as a Source Data file.
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patterns, akin to IRE1α, indicating selectivity of complementation.
The 19K-LD of AdV-D8 (D8 19K-GFP11-LD) gave only faint GFP
complementation with SS-GFP1–9-HDEL, but signals with SS-
GFP1–10-HDEL as strong as C2 19K-GFP11-HDEL, indicating
robust expression of both C2 and D8 19K-GFP11-HDEL fusion
proteins (Supplementary Fig. 4b, c). Collectively, the data show that
the C2 19K-LD closely and specifically associates with IRE1α, acti-
vates IRE1α, and triggers XBP1 splicing.
XBP1s boosts E1A and 19K, IFN-γ inhibits E1A expression.
We next asked if XBP1s directly enhanced AdV infection.
Lentivirus-mediated transduction of human XBP1s gave a dose-
dependent increase of XBP1s in HeLa I-KO cells, and increased
AdV-C2 infection (Fig. 5a). This was confirmed by qrt-PCR
measurements of E1A mRNA and 19K protein levels (Fig. 5a).
The XBP1s enhancement of E1A was dependent on the activation
domain of XBP1s, as demonstrated by expression of mutant murine
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XBP1s lacking the activation domain due to a premature stop
codon after the leucine zipper domain (Supplementary Fig. 5a).
Both wild-type and mutant XBP1s mRNAs were expressed simi-
larly, although we could only detect wild-type XBP1s in western
blots with an antibody against the C-terminal region containing the
transactivation domain. The ectopic expression of XBP1s enhanced
the E1A protein levels under the viral E1A-e/p in HeLa and HDF-
TERT cells (Fig. 5b). The application of the IRE1 nuclease inhibitor
4µ8C reduced E1A expression, indicating that both XBP1s and
IRE1α boost E1A expression in the absence of other AdV gene
products (Fig. 5b). In contrast to XBP1s and IRE1α, IFN-γ reduced
E1A expression. Notably, the XBP1s-binding sites on the E1A-e/p
are separated from the E2F co-repressor-binding sites controlled by
IFN-γ36. The enhancement of E1A expression by IRE1α and XBP1s
was further confirmed by small-interfering RNAs targeting IRE1α
and XBP1, which reduced the lentivirus-based E1A expression in
both untreated and IFN-γ-treated HeLa or HDF-TERT cells
(Fig. 5b). The treatment of HDF-TERT cells with IFN-γ also sup-
pressed AdV-C5 long-term infection, as indicated by strongly
reduced expression of the E4-GFP-Orf4 fusion protein (Supple-
mentary Fig. 5c), in agreement with the literature36.
Since reduced XBP1s levels may affect cell proliferation57,58, we
checked if XBP1s levels affected the growth of HDF-TERT cells.
Label-free, real-time impedance measurements (xCELLigence)
reporting on cell numbers, cell adhesion, and cell–cell interac-
tions59 indicated that both 4µ8C and RNAi against XBP1 reduced
cell numbers upon 2–3 days of treatment. The washout of 4µ8C
5 days post treatment restored cell proliferation, indicating that
4µ8C affected cell growth but not viability, whereas XBP1s RNAi
led to cell death 4–5 days post treatment (Supplementary Fig. 5d).
We conclude that IRE1α KO cells exhibit reduced levels of basal
XBP1s, and do not increase XBP1s upon ER stress induction. XBP1
on the other hand is essential for cell viability. Ectopic XBP1s
enhances E1A expression, even if E1A is expressed in the absence
of other viral genes.
XBP1s binds to the E1A-e/p and promotes E1A expression.
XBP1s is an integral element of the UPR, and binds to the pro-
moters of genes restoring homeostasis upon ER stress60,61. We
identified multiple elements of the ACGT and the CCACG-
binding box motifs in the E1A and the E4 promoters, and one of
each in the major late (ML) promoter, conserved in several AdV
species, including B, C, D, and F (Fig. 6a). To test if XBP1s bound
to the E1A-, E4-, and ML promoters, ChIP analysis of AdV-C2-
infected cells was performed. XBP1s antibodies enriched the E1A,
MLP, and E4-e/p regions fivefold to sevenfold over isotype con-
trol antibodies (Fig. 6b). The deletion of the four E1A XBP1s-
binding sites in E1A significantly reduced E1A expression in
HDF-TERT cells from dl309_Δ63–95 compared with dl309, most
prominently, if XBP1s was overexpressed (Fig. 6c). This result
was supported by site-specific mutagenesis of the five XBP1s-
binding sites (ACGT, CCACG, and CACG boxes) yielding AdV-
C5-XBP1s-mut, which showed strongly attenuated E1A expres-
sion compared with AdV-C5 (Fig. 6c). In accordance, the vDNA
copy numbers were four logs reduced in dl309_Δ63–195-infected
HDF-TERT cells compared with dl309 at 216 hpi (Supplementary
Fig. 6a). Similar result was obtained with AdV-C5-XBP1s-mut
compared with AdV-C5. The reduced cytopathic effects of
dl309_Δ63–195 and AdV-C5-XBP1s-mut compared with dl309
and AdV-C5 were confirmed by impedance measurements
(Supplementary Fig. 6b). We conclude that XBP1s binds to the
E1A-e/p, transactivates E1A transcription, and drives lytic AdV
infection.
The IRE1α–XBP1s axis enhances persistence. We next explored
if IRE1α–XBP1s controlled persistent AdV infections of HDF-
TERT cells. Short-term (72 h) persistent infection in the presence
of IFN-γ reduced the expression of protein VI about tenfold,
which was further reduced by RNA interference against either
IRE1α or XBP1, also in the presence of IFN-γ (Fig. 7a). In long-
term infections (22 days), 4µ8C reduced both lytic (without IFN-
γ) and persistent (in the presence of IFN-γ) infections, as
determined by E1A expression and vDNA copy numbers
(Fig. 7b).
To test if persistence depended on the E1A-e/p, we used
impedance measurements and q-PCR to monitor infections with
dl309_Δ63–195 and AdV-C5-XBP1s-mut lacking the major
XBP1s-binding sites in the E1A-e/p due to deletion or point
mutations, respectively. The E1A-wild-type viruses dl309 and
AdV-C5 were used as controls. HDF-TERT cells were seeded
onto xCELLigence plates, treated with IFN-γ, infected 36 h later,
and incubated in the presence of IFN-γ until 22.5 days post
seeding, followed by IFN-γ washout and incubation for another
13.5 days. Multiplicities of infection (MOI) of both viruses was
Fig. 3 The lumenal domain of the 19K glycoprotein activates IRE1α. a Schematic drawing showing the deletions in the E3 region of AdV mutants with
yellow boxes indicating the deletions (left panel). Infection was carried out with a median of 150 particles bound per cell. Asterisk denotes a background
product. At least three independent experiments gave similar results. Source data are provided as a Source Data file. b AdV-C5 19K enhances IRE1α
phosphorylation, XBP1s splicing, and E1A levels. Phosphorylation of IRE1α in AdV-C5- and AdV-C5-d19K-infected HDF-TERT cells (MOI 75000, 24 hpi)
was analyzed in lysates treated with or without alkaline phosphatase, and fractionated by SDS-PAGE (6%, containing 25 µM Phos-tag, first panel).
XBP1 splicing in AdV-C5- and AdV-C5-d19K-infected HDF-TERT cells 24 hpi (MOI 75,000, second panel). Immunofluorescence data of E1A are shown as
a scatterplot using n= 14,000 cells randomly chosen per condition, 24 hpi (MOI 75000). Central line of the box plot indicates median with first and third
quartiles, and whiskers are shown as boxes and lines, respectively. Statistics were performed using the Wilcoxon two-sided nonparametric test with *p <
0.0001 (third panel). Three independent experiments gave similar results. Source data are provided as a Source Data file. c Schematic depiction of lentiviral
vectors expressing the AdV-C2 E3A locus open-reading frames (left panel). Premature termination of C2 E3A genes encoding the membrane proteins 7.1K,
and ADP maintains XBP1s induction, whereas premature termination of 19K abolishes it (second panel). Data show the means from two technical
replicates. Two independent experiments gave similar results. The western blot in the last panel displays activated phosphorylated (p) and
unphosphorylated PERK (o). Source data are provided as a Source Data file. d Chimeric and mutant 19K constructs lacking transmembrane and cytoplasmic
domains or the MHC-I binding site (M87A mutant) can induce XBP1s (left and middle panels). The wild-type lumenal, transmembrane, and cytoplasmic
domains are labeled as L, T, and C, respectively, whereas mutant murine MHC-I domain replacing them is labeled as K56. The relative 19K expression levels
in HeLa cells are shown in the right panel after Tw1.3 staining. Data are presented as mean from two technical replicates, and two independent experiments
gave similar results. Source data are provided as a Source Data file. e Expression of the lumenal domain (LD) of C2 19K with a Flag tag, and a C-terminal ER
retention signal (HDEL) is sufficient to induce XBP1s to levels similar as from the full-length 19K construct (left and middle panels). Immunofluorescence
staining with the anti-19K 3A9 antibody in parallel samples depicts the expression levels of the full-length and the lumenal 19K proteins (right panel, scale
bar, 50 µm). Data show a scatterplot of 20,000 randomly chosen cells per sample. Central line of the box plot indicates median with first and third
quartiles, and whiskers are shown as boxes and lines, respectively. Source data are provided as a Source Data file.
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chosen such that similar cytopathic effects occurred without IFN-
γ treatment at 120 h post seeding (Fig. 7c, right panel, see also
E1A expression data in Supplementary Fig. 7b). While dl309 and
AdV-C5 infections led to cell death after 12.5 and 11 days,
respectively, in the presence of intermittent amounts of IFN-γ,
the dl309_Δ63–195 and the AdV-C5-XBP1s-mut-infected cells
remained viable throughout the course of the experiment to about
36 days (870-h time point), akin to uninfected cells (Fig. 7c).
Under IFN-γ, the titers of dl309_Δ63–195 and AdV-C5-XBP1s-
mut did not rise (middle panel), and the cells remained viable as
shown by phase-contrast microscopy and impedance measure-
ments using xCELLigence, indicative of only low levels of
persistence, whereas titers of dl309 or AdV-C5 increased by
102−103-fold, indicating high persistence of E1A normal viruses
(Fig. 7c). Importantly, upon removal of IFN-γ 22.5 days post
seeding, the dl309_Δ63–195 and AdV-C5-XBP1s-mut titers
increased several hundred to a thousand-fold 36 days post
seeding, while the dl309 or AdV-C5 infections lead to rapid cell
death. These results demonstrate that the XBP1s-binding sites in
the E1A-e/p support the persistence under IFN-γ. The data show
C2 19K-LD complements GFP with IRE1α-LD not PERK-LD
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Fig. 4 19K forms a complex with IRE1α in the ER. a Schematic representation of tripartite split-GFP lumenal domain (LD) constructs used in ER-lumenal
GFP complementations. Green fluorescence is restored when proteins containing the GFP10 and GFP11 domains are in close proximity together with the
core GFP1–9 targeted to the ER lumen. b Interaction of C2 19K-LD with IRE1α-LD but not PERK-LD. HeLa cells co-transfected with C2 19K-LD-GFP11, SS-
(signal sequence)-GFP1–9-HDEL, and Flag-IRE1α-GFP10 or PERK-LD-GFP10 were fixed and stained with anti-19K (3A9) and anti-Flag antibodies and DAPI
(nuclei). Confocal images were segmented with CellProfiler using DAPI as a nuclear mask, and the reticular ER signal was measured in a ten-pixel area
around the nuclei. Arrows indicate high-intensity split-GFP complementation signals in IRE1α-LD-transfected cells, and arrowheads low-intensity split-GFP
complementation. Zoomed in representative immunofluorescence micrographs of split-GFP complementation in SS-GFP1–9-HDEL, IRE1α-LD-GFP10, and
C2 19K-LD-GFP11-transfected cells. Cells were imaged with Leica SP8 microscope using Nyquist x–y–z sampling with ×63 objective. Following acquisition,
images were deconvolved using SVI Huygens using theoretical point-spread function (PSF) automatically calculated from the imaging parameters. Split-
GFP complementation signals appear in the region of ER tubules where 19K and IRE1α colocalize. Flag and 19K-positive cells (n= 492 for IRE1α-LD and n=
40 for PERK-LD) were plotted for GFP intensity, and the percentage GFP-positive cells is indicated. Data are presented as median with first and third
quartiles, and whiskers as boxes and lines, respectively. Statistical tests were performed using Wilcoxon two-sided nonparametric test, and two
independent experiments gave similar results (lower right panel).
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AdV-C2, 24 h pi
2
Fig. 5 XBP1s enhancement of E1A and 19K levels depends on the E1A promoter. a The expression of human XBP1s (hXBP1s) enhances E1A and 19K
expression and infection. Dose-dependent expression of hXBP1s in HeLa I-KO (IRE1α-knockout) cells transduced with lentivirus vectors for 72 h (first
panel). AdV-C2-dE3b-mCherry infection (MOI 100) is rescued in HeLa I-KO cells by hXBP1s expression, where the cells were transduced with lentiviruses
for 2 days and infected with AdV-C2 for 24 h (second panel). Data are presented as mean from two technical replicates, and two independent experiments
gave similar results. qrt-PCR showing the rescue of E1A mRNA by hXBP1s overexpression in AdV-C2-(MOI 75) infected HeLa I-KO cells. Data are
presented as mean ± SD from three independent experiments (third panel). Increased 19K protein levels by hXBP1s expression in AdV-C2-(MOI 75)
infected HeLa I-KO cells (n= 3627 and 2317 for lenti-empty and lenti-hXBP1s, respectively, fourth panel). Data show the medians and first and third
quartiles, and whiskers as boxes and lines, respectively. Statistical analyses were done by two-tailed Wilcoxon nonparametric tests with significance *p <
0.001. Two independent experiments gave similar results. b E1A expression from the E1A-e/p can be increased by ectopic XBP1s, or reduced by the IRE1α
inhibitor 4µ8C in HeLa cells (left panel). A similar experiment was carried out in HDF-TERT cells including IFN-γ to suppress the E1A promoter/enhancer
expressed from a lentivirus vector (middle panel). E1A expression in HDF-TERT cells is reduced by RNA interference against IRE1α and XBP1, but not by
nontargeting siRNA (siNeg1, 20 nM siPools, right panel). Error bars represent standard deviations. For all the graphs, data are presented as mean from two
technical replicates, and two independent experiments gave similar results.
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that noncanonical activation of IRE1α maintains a feedforward
loop between the ER and the nucleus, gives rise to E1A and 19K
expression, maintains AdV persistence, and boosts lytic infection
(Fig. 7d).
Discussion
AdVs encode several immune-modulatory membrane proteins.
We showed that the E3-19K glycoprotein of species C2/5 but not
of the divergent D8 AdV is necessary and sufficient to selectively
activate IRE1α, but not PERK, ATF6, and RIDD, see also ref. 59.
Activations of PERK and RIDD normally restore homeostasis
upon ER stress by phosphorylation of the eukaryotic initiation
factor 2 GTPase inhibiting global protein synthesis, and degrad-
ing mRNA and microRNAs, respectively45,62. This is in accor-
dance with unabated protein production at the time of full IRE1α
activation, that is no loss in Flag-hIRE1α, BiP, or β-tubulin,
indicating that AdV does not activate the UPR to inhibit protein
synthesis. The ensuing 19K expression and association of the
19K-LD with the IRE1α-LD induced IRE1α phosphorylation and
XBP1 mRNA splicing yielding XBP1s. These results are compa-
tible with proteomics data showing that XBP1s levels are
increased in AdV-infected cells63.
Remarkably, AdV-infected cells dissociated BiP from IRE1α
before XBP1 splicing, and independent of 19K expression, but
dependent on E1A, indicating that the E1A protein, its mRNA,
or an E1A-controlled gene product dissociates BiP from IRE1α.
This may be akin to a subset of ER-targeted cellular mRNAs,
signal recognition particle RNA, ribosomal RNAs, or transfer
RNAs, which can directly activate IRE1α64. The noncanonical
UPR induction by AdV contrasts the known cellular and viral
UPR inductions. Lumenal peptides can bind to both BiP and
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Fig. 6 XBP1s binds to predicted sites on the AdV E1A and E4-e/p. a Schematics depicting the XBP1-binding sites (blue and red boxes) and consensus-
binding sequences on the E1A, E4, and major late (ML) promoters in AdV-C5 genome. The letter psi denotes the packaging sequence near the inverted
terminal repeat (ITR). The yellow box on the right shows the conservation of predicted XBP1s-binding sites in the E1A and E4 promoters in different human
AdV types. b Chromatin immunoprecipitations from AdV-C2-infected cells using anti-XBP1s and control IgG antibodies. The data show the fold enrichment
of XBP1s on the AdV-C2 promoters (in particular the E1A and the E4 promoters) with anti-XBP1s versus control antibodies, as calculated using precleared
chromatin as input36. Data show the means from three technical replicates. Two independent ChIP experiments gave similar results. c The deletion and
mutagenesis of the XBP1s-binding sites on the E1A enhancer/promoter (e/p), nucleotide positions 63–195 reduce the E1A expression in normal cells and
cells ectopically expressing XBP1s. E1A expression analyses in control or hXBP1s-transduced HDF-TERT cells infected with C5-dl309 or the mutant virus
C5-dl309-∆63–195, and E1A expression analysis in AdV-C5 and mutant (mut) AdV-C5-XBP1s-mut-infected HDF-TERT cells (MOI 75000). Eight thousand
cells per condition, including non-infected cells (n.i.), were chosen by random sampling of the total data. The mutagenized E1A-e/p region in AdV-C5-
XBP1s-mut virus is shown on the right side with A<>C and G<>T substitutions. Data show the medians and first and third quartiles, and whiskers as boxes
and lines, respectively. Statistics were performed using two-tailed Wilcoxon nonparametric test with *p < 0.0001. Three independent experiments gave
similar results.
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triggers the transition of IRE1α from a closed to an open con-
formation, and leads to IRE1α oligomerization65. Consequences
of IRE1α activation comprise inflammatory reactions in con-
junction with activation of pattern recognition receptors66. The
LD of C2 19K and IRE1α was in close association based on
immunoprecipitations and split-GFP complementation assays.
This mode of IRE1α activation contrasts with a recent lipid
stress activation model of IRE1α, where BiP binding to IRE1α is
not affected43,67. Importantly, IRE1α activation by C2 19K was
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indicating that MHC-I sequestration and prevention of CTL-
mediated killing of infected cells are not required for IRE1α
activation.
The initiation of XBP1 mRNA splicing is a key output from
activated IRE1α reviewed in refs. 9,68. XBP1s is central in boosting
lytic and persistent AdV-C2/5 infections. Lytic infection could be
rescued by overexpression of XBP1s in IRE1α KO cells. More
specifically, XBP1s was found in a complex with the E1A-e/p in
infected cells, and boosted E1A (and also 19K) expression, and
lytic infection. The XBP1s-binding sites on the E1A-e/p are dis-
tantly located from the E2F-Rb repressor-binding sites36, a con-
figuration that allows for coregulation by repressors and
stimulators, which we show here is crucial in AdV persistently
infected cells in the presence of IFN-γ. The concept of cor-
egulation by activators and repressors is found with herpes
viruses and HIV, where transcriptional coregulation occurs dur-
ing persistence69,70. In accordance, the IRE1α nuclease inhibitor
4µ8C, which reduces XBP1s, reduced AdV-C5 persistence in
HDF-TERT cells under IFN-γ.
The C2/5 19K glycoprotein of the E3 region together with the
transcriptional activator E1A is important to maintain the levels
of XBP1s, as indicated by infection of HDF-TERT cells with
AdV-C5-Δ19K. 19K activates IRE1α, which increases XBP1s, and
XBP1s enhances E1A transcription. This supports both lytic and
persistent infection of HDF-TERT cells, as indicated by AdV-C5
mutants lacking functional XBP1s-binding sites in the E1A-e/p.
In nonlymphoid cells, the E3 promoter, which lacks XBP1s-
binding sites is controlled by E1A, and in lymphoid cells, it is
E1A-independent but NF-κB dependent71. This may lead to cell
death. For example, TNFα exposure induces ER stress, IRE1α,
and NF-κB activation, and exacerbates death signaling through
the TNF receptor 1, involving c-JUN N-terminal kinase72. If and
how AdV antagonizes this signaling pathway is unknown.
Alternatively, other host transcription factors could be involved
in E3 regulation. For example, SP1, which is induced by XBP1s60
has 29 predicted binding sites in the E3 promoter, and could
enhance E3 transcription. Regardless of the nature of the E3
promoter regulation, the deletion of the 7.1K and 19K region in
AdV-C5 reduced viral persistence in Syrian hamsters73. Our data
highlight the therapeutic potential of the IRE1α branch of the
UPR, and converge on the notion that in Zika virus-infected
human and mouse embryos, the UPR was observed in the cere-
bral cortex of postmortem fetuses, and the IRE1α nuclease inhi-
bitor 4µ8C reduced the microcephaly frequency74. In conclusion,
the selective activation of IRE1α by 19K provides an environment
conducive for AdV persistence, and supports the lytic cycle under
conditions of impaired immunity.
Methods
Cells and viruses. A549 and HeLa-ATCC cells were obtained from American
Type Cell Culture (ATCC). HCE cells were obtained from Dr Niklas Arnberg
(UMEA University, Sweden). Human diploid fibroblasts immortalized with telo-
merase (HDF-TERT)75 and other cells were grown at 37 °C in 5% CO2 environ-
ment in DMEM (Sigma) supplemented with 10% fetal calf serum (FCS). For
generation of the AdV-C2_dE3B-mCherry virus, the GFP ORF in AdV-
C2_dE3B_GFP55 was replaced with the mCherry ORF. The virus genome was
cloned into pKSB276, followed by two homologous recombination steps according
to the recombineering protocol numbers 1 and 377. Note that the MOI varied
between different experiments and viruses depending on the susceptibility of the cells,
the nature of the experiment (persistence/lytic/early/late infection readout), and the
infection protocol (warm or cold-synchronized infection). For generation of AdV-C5-
E3-Δ19K and AdV-C5-XBP1s-mut viruses, AdV-C5 (wt300) DNA78 was inserted into
pKSB276 followed by two homologous recombination steps according to the recom-
bineering protocol numbers 1 and 377. Insertion of the sequence 5′-ATTTATTGTC
AGCTTTTTAAACGCTGGGGTCGCCACCCAAGATGATTTACTAAGTTACAA
AGCTAATGTCACCACTAACTGCTTTACTCG-3′ in the second step introduced a
complete deletion of the 19K ORF except the first 4 nt, allowing to keep the over-














E1A-e/p region introduced XBP1s-binding sites mutagenized using A<>C; G<>T
substitution rule (AdV-C5-XBP1s-mut, Fig. 6c). All the indicated MOI were calculated
as the estimated number of viruses per cell where virus titer was determined by q-PCR
based described in the section “Virus titer estimation.” For specific reagents, see
Supplementary Table 1.
Cas9 knockout of IRE1α in HeLa-ATCC cells. HeLa-ATCC and 293T cells were
transduced with Lentiviral vector expressing Cas9 (Addgene, 49535) and a guide
RNA against exon 2 of mammalian ERN1 (IRE1α, chromosome 11)79. A poly-
clonal population of both cell lines expressing Cas9 was selected with puromycin
(2 µg/ml), and single clones were isolated from HeLa-ATCC. For selection of clonal
population, a polyclonal population was seeded at high dilution in a 15-cm dish
and allowed to grow into several sparse clones. Using circular rings, small popu-
lations from single clones were trypsinized, collected, and seeded on 96-well clear-
bottom plates for expansion. After several weeks, DNA from the growing clonal
population was extracted, and using primers flanking the target site of Cas9 on
exon 2 of IRE1α, PCR was performed, and fragments were ligated into plasmid
vector (Bluescript). Positive clones were sequenced, aligned to the wild-type
Fig. 7 IRE1α and XBP1s facilitate persistent and lytic AdV infections. a Reduction in late AdV-C5 protein VI expression (MOI 180) of HDF-TERT cells
upon RNA interference against IRE1α and XBP1 in the presence or absence of IFN-γ, including nontargeting siRNA (siNeg1). Data show the means ± SD
from three independent experiments (n= 3). b E1A expression of AdV-C5-infected HDF-TERT cells (MOI 200, 37 °C, 1 h) with or without 500 IU IFN-γ, or
IRE1α RNase inhibitor 4µ8C (100 µM) at 13 days pi was analyzed by immunofluorescence showing representative images (left) and a scatterplot with
15,000 cells per condition (middle). Data show the median, first and third quartiles, and whiskers as boxes and lines, respectively. Significance was
assessed with two-tailed Wilcoxon nonparametric test (middle panels). Virus titers (q-PCR, right panel) were determined after 5 days of incubation with
the drug (18 d pi). Q-PCR data show the means from two technical replicates. Two independent experiments gave similar results. Scale bar, 100 µm.
c xCELLigence impedance plots showing HDF-TERT cell viability upon dl309 or dl309-63/195 and AdV-C5 or AdV-C5-XBP1s-mut infections (MOI 200).
Cells were seeded on xCELLigence E-16 plate, and impedance readout for cell viability was measured live at 15-min intervals. Data show the means ± SD
from three technical replicates. Two independent experiments gave similar results (left row). Experimental conditions and virus amount were as in panel
b Genome copy numbers of virions released to the supernatant from the same experiment. Data show the means from two technical replicates. Two
independent experiments gave similar results (middle row). Representative phase-contrast images of parallel samples imaged live for dl309 or dl309-63/
195 infections (images on the right side, scale bar, 200 µm). d Schematic model depicting AdV infection under the control of a five-component feedforward
loop. (1) The immediate early E1A protein transactivates early promoters. including the E3 and E4, giving rise to the 19K glycoprotein (2). Activation of
IRE1α by 19 K increases XBP1s mRNA, and XBP1s protein (3), which translocates into the nucleus, and binds to the E1A enhancer/promoter (e/p) of the
episomal viral genome (4). Binding of XBP1s to the E1A-e/p increases the E1A levels (5), which enhances output from the E3 promoter, enhances the 19K
levels, and maintains a feedforward loop supporting viral persistence and lytic infection.
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mammalian IRE1α locus (NCBI identifier NC_000017.11 region 64039142–
64132469), and the resulting mutations were identified. As IRE1α is triploid in
HeLa cells80, sequencing of the clone used in this study revealed three distinct
mutations, namely insertion of A, frameshift deletion of 23 nt, and in-frame
deletion of 15 nt (Supplementary Fig. 1b).
Lentivirus production, cloning, and transduction. The cDNA inserts for human
IRE1α43, human XBP1s (Addgene 63680, NCBI Gene ID 7494), mouse XBP1s
(NCBI Gene ID 22433), AdV-C5 E1A enhancer, promoter, and E1A expression
cassette (1-1701 genomic region from AdV-C5 genome NCBI AC_000008.1) were
cloned into PLVX-IRES-Puro (Clontech 632183). Lentiviral vectors were produced
in HEK293T cells by transfecting lentiviral construct, pCMVR8.91-Gag-Pol and
pVSV-G (Clontech)81. Relative titers of different lentiviruses were determined
using dose–response of puromycin 72 h post transduction. For transduction of
cells, predetermined amounts of lentivectors that gave good expression of the target
gene were added to cells at the time of seeding, and transduction was performed for
48 h. Cells were either collected for analyses of the transgene expression levels by
western blotting or for chromatin immunoprecipitation or infection assays, as
indicated.
For the ectopic expression of AdV-C2 and D8 E3-19K (Genbank AB448767.1)
in the absence of other viral factors, an expression system was developed where
codon-optimized AdV-C2 E3-19K construct after the N-terminal calreticulin signal
sequence (Css) was synthesized by GeneArt/Life Technologies and inserted into
pSG5 expression vector82 (pSG5-19K-CO Css). For insertion of AdV-D8 E3-19K
in the same construct, D8 E3-19K ORF after the wild-type signal sequence was
amplified by PCR from purified vDNA and substituted with the C2 E3-19K
sequence in pSG5-19K-CO Css plasmid after the Css sequence using NEBuilder®
HiFi DNA assembly cloning kit (New England Biolabs). Lumenal domain (LD)
19K-LD-Flag-HDEL mutants of C2 and D8 19K were made by the deletion of the
transmembrane and cytoplasmic domains of E3-19K and insertion of Flag-HDEL
domain by site-directed mutagenesis using the Q5® Site-Directed Mutagenesis Kit
(New England Biolabs). The correctness of all the constructs was verified by
sequencing.
Transfection and infection. For knockdown experiments, siPoolsTM oligos
(siTools Biotech GmbH, Martinsried, Germany) were used. siPools have minimal
off-target effects due to subthreshold concentrations of individual dsRNAs83.
siRNAs were mixed with 9.8 µl of Opti-MEM medium (Invitrogen) and Lipo-
fectamine RNAiMax reagent (0.2 µl/well, Invitrogen), and incubated at room
temperature for 5 min in a 96-well plate (Greiner). Ten thousand HeLa-ATCC or
HDF-TERT cells were added in 90 µl per well of DMEM medium supplemented
with 10% FCS of the 96-well plate and incubated at 37 °C in a 5% CO2 environ-
ment for 48 h. After this, continuous infection with AdV-C5 or AdV-C2-
dE3B_mCherry was carried out for 24, 48, or 72 h. Multiplicity of infection (MOI)
was calculated from the absorbance of purified particles at 260 nm in the case of
AdV-C5_dl309 or dl309_∆63–195, by the infectious titer determined in A549 cells,
or as indicated.
For HeLa cells, the final concentration of 10 nM, and for HDF-TERT cells, 20 nM
of siPools were transfected, based on knockdown efficiency. For the rescue of
infection in knockout cells, cells were transduced with lentivectors expressing human
XBP1s or IRE1α for 48 h, incubated with indicated viruses for 24 h followed by
fixation and staining with protein VI or E1A (M58). Control cells were transduced
with lentivectors devoid of the transducing gene. Further analysis was done with
high-throughput microscopy, western blotting, or quantitative PCR as
described below.
For transfection of split-GFP constructs in HEK293T cells, 100 ng of each
construct per well of the 96-well plate was mixed with 9.8 µl of Opti-MEM
medium (Invitrogen) and Lipofectamine 2000 reagent (0.2 µl/well, Invitrogen),
and incubated at room temperature for 5 min after directly spotting on a 96-well
plate (Greiner). Ten thousand HEK293T cells were added in 90 µl of DMEM
medium supplemented with 10% FCS per well of the 96-well plate and incubated
at 37 °C at 5% CO2 for 48 h. Cells were fixed 48 h post transfection and stained
with anti-E3-19K (3A9) and anti-Flag antibodies followed by imaging and
analysis as described in the section called high-throughput imaging and
measurement of infection. Representative images of split-GFP constructs for
Fig. 4b were taken with a confocal SP5 microscope (Leica) and maximal
projection images are shown.
For Neon transfection (Thermo Fisher Scientific) of E3-19K constructs in
HeLa-ATCC cells, 5 µg of the plasmid DNA was mixed with Resuspension buffer
(Neon) at a density of 0.5 × 107 cells/ml and filled in the Neon Tip (100 µl of
plasmid plus buffer) attached to the Neon Pipette. Neon Tube was filled with
electrolytic buffer and attached to the Neon Pipette Station. The cells were
electroporated at 1005-V pulse voltage, at 35-ms pulse width, and two pulses.
Following this, the cells were resuspended in antibiotics-free DMEM medium
supplemented with serum (FCS) and seeded on the 6-well plate for RNA extraction
or western blotting or 96-well plate for immunofluorescence staining. Twenty-four
hours after transfection, cells were either collected for RNA extraction or fixed and
DAPI stained for the calculation of the percentage E3-19K-expressing cells.
XBP1-splicing assay. Total RNA from HeLa-ATCC and HDF-TERT cells was
lysed in Trizol Reagent (Invitrogen) and extracted using the Direct-zol RNA
MicroPrep kit (Zymo Research). The cDNA synthesis was carried out with MMLV
RT (Promega, M170) using Oligo dT 15 mer primers (Promega, C1101). PCR
amplification for XBP1 gene was performed, and products were digested with PstI
and treated with T7 Endonuclease (NEB, E3321) to get rid of the hybrid
XBP1s–XBP1u bands (Supplementary Fig. 1f). The DNA bands were resolved in
2% agarose gel and images were taken with GeneSnap (Syngene).
IRE1α and PERK mobility shift assay. Activation of PERK signaling arm of UPR
was checked using the electrophoretic mobility shift assay. Hyperphosphorylated
forms of PERK were detected by sufficiently resolving the 1-h DTT-(10 mM)
treated cell lysates in 4–20% gradient gels (Biorad), and detecting the protein using
anti-PERK antibody (Cell Signaling). For separating the phosphorylated from
hypophosphorylated forms of IRE1α, 6% polyacrylamide gels containing 25 µM
Phos-tag (Fujifilm WAKO) and ZnCl2 was used. All buffers were prepared as
described by the manufacturer (https://www.igz.ch/downloads/16079/phos-
tagtm_sds-page_guidebook_11.pdf), and Phos-tag-bound proteins resolved on the
polyacrylamide gels were incubated with 10 mM EDTA for 10 min prior to
transferring them to PVDF membranes to reduce the adverse effects of Zn2+ on
protein transfer efficiency.
Immunoprecipitation and immunoblotting. HeLa-ATCC, Flag-IRE1α-MEFs, or
293T cells were seeded on 10-cm dishes. Twenty-four hours later, cells were
infected with AdV-C2 (MOI 100 for HeLa-ATCC or twofold higher for Flag-
IRE1α-MEFs) at 37 °C, 5% CO2 for 24 h. Following this, the medium was aspirated
and washed with ice-cold PBS several times. Cells were scraped in 600 µl of DMEM
and collected in 1.5-ml tubes. Cells were pelleted and resuspended in 600 µl of ice-
cold IP lysis buffer (Tris-HCl, pH 8.5, NaCl 150 mM, MgCl2 1 mM, EDTA 1mM,
Nonidet P-40 0.5%, and protease inhibitor cocktail) under agitation at 4 °C for
20 min. The cells were centrifuged at 16,000 × g at 4 °C for 10 min, and the
supernatant was collected. Fifty microliters of the cell lysates were kept for an input
control sample and the rest was precleared with protein-A sepharose beads
(Abcam, ab193256). Precleared lysates were incubated with anti-3A984, anti-Flag
(Sigma, F7425), or an equivalent amount of IgG control overnight at 4 °C. The
next day, 30 µl of Protein-A sepharose beads were added per sample and incubated
at 4 °C for 1 h with agitation. Beads were spun down, the supernatant removed, and
beads washed in IP lysis buffer several times. After this, the beads were mixed with
2× SDS lysis buffer (10% w/v), boiled at 95 °C for 5 min, and the supernatant was
collected. Samples were resolved with polyacrylamide gel electrophoresis after
addition of DTT (50 mM) for anti-Flag and without DTT for anti-3A9 immuno-
blotting. For immunoprecipitations of Flag-IRE1α from Flag-IRE1α-expressing
MEFs and lumenal domain of IRE1α-expressing HeLa cells, the ratio of BiP to
IRE1α in the IP fraction was normalized to their respective levels in the lysate.
Tripartite split-GFP protein interaction assay. The tripartite split-GFP com-
plementation assay was modified based on earlier protocols85,86. For the con-
struction of tripartite split-GFP plasmids, lumenal domains of E3-19K from AdV-
C2 or D8, and Flag-tagged human IRE1α or PERK was PCR amplified (Supple-
mentary Table 2) and inserted into pcDNA 3.1 plasmid having the GFP11 and
10 domains, respectively. The rest of the GFP1–9 and GFP1–10 domain was
inserted after Css at the N terminus and ER retention signal HDEL at the C
terminus and cloned in pcDNA 3.1. For full-length split-GFP constructs shown in
Supplementary Fig. 4b, IRE1α-GFP11 and 19K-GFP10 pair was chosen due to the
better signal:noise ratio of this pair. For IRE1α, GFP11 domain was inserted at the
linker region after the transmembrane domain of IRE1α. The rest of the GFP
domains 1–9 were cloned in pcDNA 3.1. One hundred nanograms of all the
plasmids were transfected in HeLa or 293T cells using Lipofectamine transfection
method. Forty-eight hours later, cells were fixed with 3% paraformaldehyde (PFA)
and stained with anti-Flag and anti-E3-19K (3A9) antibodies and imaged with
high-throughput and confocal microscopes to measure the expression levels. The
number of cells was determined with DAPI staining. Total tripartite split-GFP
puncta were identified using custom-made CellProfiler script (Supplementary
Table 4) and plotted using JMP 13.
Chromatin immunoprecipitation. HeLa-ATCC cells (~1 × 106 cells) grown on a
10-cm dish were transduced with lentivirus vector expression human XBP1s.
Forty-eight hours after transduction, cells were infected with AdV-C5 at a MOI of
1200 at 37 °C for 1 h. Unbound virus was washed away, and infection was con-
tinued for 23 h after which the medium was replaced with 5 ml of DMEM, and
cross-linking with 333 µl of 16% PFA was done for 10 min and 37 °C. Cross-linking
was stopped by the addition of 761.85 µl of glycine (125 mM) at RT for 5 min. After
this, cells were washed twice with ice-cold PBS, scraped off the plate, and collected
with 600 µl of PBS. Cells were pelleted by centrifugation at 1000 g at 4 °C for 5 min
and resuspended in 600 µl of SDS lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM
EDTA, 1% SDS, and freshly mixed with protease inhibitor cocktail, Roche
4693159001) at 4 °C for 10 min. Shearing of the cells was performed with Covaris
S2 using Duty cycle 10, intensity 5, cycles 3, cycles/burst 200, and time/cycle of 60 s.
Samples were centrifuged at high speed to remove cellular debris. One microgram
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of chromatin was kept for input determination. Ten micrograms of chromatin-
containing cell lysates were diluted tenfold with dilution buffer (Tris-HCl, pH 8.0,
NaCl 167 mM, EDTA 1.2 mM, SDS 0.01%, and Triton X-100 1.1%) and precleared
with protein-A agarose/salmon sperm DNA slurry (Millipore) with rotation at 4 °C
for 1 h. Cell lysates were spun to remove precleared complexes and incubated with
3 µg of anti-XBP1s (BD Biosciences) and Rabbit-IgG isotype control (Thermo
Fisher Scientific) overnight at 4 °C with rotation. Immune complexes were captured
by incubation with protein-A agarose/salmon sperm DNA slurry (Millipore) at
4 °C for 2 h and pelleted by centrifugation (2000 × g for 1 min). Washing with low-
salt buffer (20 mM Tris-HCl, pH 8.0, NaCl 167 mM, EDTA 150 mM, SDS 0.1%,
and Triton X-100 1%), high-salt buffer (20 mM Tris-HCl, pH 8.0, NaCl 500 mM,
EDTA 2mM, SDS 0.1%, and Triton X-100 1%), LiCl wash buffer (10 mM Tris-
HCl, pH 8.0, LiCl 0.25 M, EDTA 1mM, SDS 1%, Triton X-100 0.5%, and sodium
deoxycholate 1%), and TE buffer (Tris-HCl, pH 8.0, 10 mM EDTA, 1 mM) was
performed, and elution with elution buffer (NaHCO3 100 mM, SDS 1%) was done
by incubation with rotation at room temperature for 15 min. Reverse cross-linking
for formaldehyde complexes was done by incubation with 5 M NaCl, 0.5 M EDTA,
1M Tris-HCl, and proteinase K (20 mg/ml) at 65 °C overnight. DNA was extracted
using the Qiagen blood and tissue extraction kit and subjected to quantitative PCR
using primers listed in Supplementary Table 2. Data were plotted as fold enrich-
ment relative to input.
Virus titer estimation. Long-term persistent AdV-C5-infected HDF-TERT cells
were washed with PBS and collected after scraping of the cells from the plate. DNA
extraction was performed with Qiagen blood and tissue kit (Qiagen, #69504), and
viral genome copy numbers were determined using quantitative PCR with primers
on the AdV E1A enhancer region (Fwd 5′-GGTGGAGTTTGTGACGTGG-3′ and
Rev 5′-CGCGCGAAAATTGTCACTTC-3′). First the relative abundance of E1A
templates was calculated using ∆∆Ct method and normalized to the cellular PDK1
gene (see Supplementary Table 2). Afterward, absolute viral gene copy numbers of
one of the infected samples were calculated with an E1A standard curve using a
plasmid DNA containing the E1A promoter and enhancer region followed by
relating it to the relative fold difference derived from the ∆∆Ct method above.
Details of the quantitative PCR are mentioned in the section about
quantitative PCR.
Establishment of persistent AdV infection. HDF-TERT cells were incubated with
IFN-γ (500 IU/ml) for 24 h prior to infection. Infection with AdV-C5 (MOI 25) was
performed in the presence of IFN-γ for 14 h; cells were washed and incubated with
IFN-γ. For establishment of long-term persistence, the medium and fresh IFN-γ were
replaced every 5 days until the end of the experiment36.
Promoter activity assays. The AdV-C5 E1A gene under the E1A enhancer and
promoter elements (genomic region 1-1701 of AC_000008.1) were cloned in
pLVX-IRES-Puro lentivector (Clonetech) and used to transduce HeLa-ATCC and
HDF-TERT cells along with empty and human XBP1s lentivectors. Forty-eight
hours post transduction, 4µ8C (100 µM) or IFN-γ (500 IU) were added to the cells.
Seventy-two hours post transduction, cells were fixed with PFA and stained with
anti-E1A (M58). The percentage of E1A-expressing cells was determined using
custom-made CellProfiler script and data analyzed with Knime software.
High-throughput imaging and measurement of infection. After fixation and
staining, cells were imaged with high-throughput wide-field microscope (Molecular
Devices IXM-XL). DAPI staining was used to segment the nuclear mask for the
cells, and the intensity of E1A (M58 and 73) and protein VI was measured over this
mask using CellProfiler87. For the reticular staining of split-GFP and E3-19K
staining, nuclear mask was expanded by ten pixels, and E3-19K intensity was
measured over this ring-shaped object. The separation of mCherry, E1A, protein
VI, or E3-19K-expressing and nonexpressing cells was calculated with KNIME, and
graphs were plotted either in JMP version 13 or GraphPad Prism version 8.
Western blotting. At the time of anlaysis, cell lysates were collected in lysis buffer
(0.2 ml of 200 mM Tris, pH 8.8, 20% glycerol, 5 mM EDTA, 50 mM DTT, 5% SDS,
and 0.02% bromophenol blue) by boiling at 95 °C and shearing through G21
needles (Sterican). Proteins were resolved in polyacrylamide gels and transferred to
a polyvinyldifluoride membrane (Amersham). Blocking of unspecific protein-
binding sites of the membrane was done with 5% milk powder. Primary antibody
incubation was performed at 4 °C, followed by horseradish peroxidase (HRP)-
tagged secondary antibody incubation at room temperature. Protein bands were
visualized by incubation with chemiluminescent reagent (Amersham) and the
Amersham Imager 600.
Quantitative rt-PCR. Cells were lysed in Trizol Reagent (Invitrogen) and total
RNA extracted using the direct-zol RNA MicroPrep kit (Zymo Research). cDNA
synthesis was carried out with MMLV RT enzyme (Promega, M170) using Oligo
dT 15 mer primers (Promega, C1101). The amplification was done using SYBR
Green JumpStart Taq ReadyMix in Applied Biosystems Quant Studio 3 Real-Time
PCR System with primers listed in Supplementary Table 2. For ChiP experiments,
the relative quantification procedure of the Pfaffl method was used to convert the
average Ct values for each sample to relative fold-change information88.
xCELLigence impedance measurements. For measuring cell toxicity of AdV and
chemicals, the xCELLigence impedance measurement (Roche Applied Science and
ACEA Biosciences) was used59,52. For AdV toxicity in lytic or persistent infections,
cells were seeded on E-16 plates for 48 h, followed by incubation with IFN-γ
(persistent infection) for 24 h and incubation with AdV at 37 °C for 1 h. Cells were
either further incubated with IFN-γ (persistent infection), or with normal medium
(lytic infection), and cell index measurements were recorded live at intervals of
15 min. For assessing the effects of 4µ8C on cell viability, cells were seeded and
incubated with 4µ8C for 7 days followed by drug washout.
Click chemistry and visualization of single viral DNA dots. HeLa wild-type and
I-KO cells were seeded on alcian-blue-coated coverslips and infected with EdC-
labeled AdV-C5 virus at 37 °C for 1 h, followed by washout of unbound virus and
further incubation at 37 °C for 1.5 h. Cells were fixed with formaldehyde and
analyzed for capsid-free vDNA by copper-catalyzed click chemistry39. Viral capsids
were stained with antihexon antibody (9C12) and samples imaged with an SP8
confocal microscope (Leica)52. Maximal projections of signals were analyzed with
CellProfiler where DAPI staining was used to identify a nuclear mask together with
overexposed hexon signals to segment the cell boundaries. Viral capsids, vDNA
over the nucleus and in the cytoplasmic area was counted, and the distribution of
capsid-free vDNA over nuclei and the cytoplasm calculated.
Prediction of SP1-binding sites in the E3 promoter. An overall consensus around
the GC-box core element GGGCGG of SP1-binding sites can be predicted at http://
tfbind.hgc.jp/89. Accordingly, up to 34 putative binding sites around the GC box
were predicted in the E3 promoter, and 29 of them have a predicted consensus
match for SP1 binding.
Quantifications and statistical analysis. Statistical analyses were performed
using JMP version 13. For statistical analysis used in Figs. 5a and 6c, pairwise
Wilcoxon nonparametric tests were performed.
We declare that no data have been excluded from experimental replicates.
Random sampling in Figs. 6c and 7b as well as S4 d was done to keep an even
number of cells analyzed between samples.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available within the article and its
Supplementary Information files, or are available from the authors upon request. The
source data underlying Figs. 1–3 and 5a, and Supplementary Figs. 1e, 2b–e, 3a, b, d–i, 4a,
and 5a are provided as Source Data files.
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